Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 1/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9757929 | 0.92 | CYP4F2 (0.36) | CYP4F2CYP4A11ALDH1A1LMNAMAPT | |
| SCHEMBL9757879 | 0.90 | CYP4F2 (0.38) | TLR4CYP4F2CYP4A11ALDH1A1LMNA | |
| SCHEMBL9757893 | 0.88 | CYP4F2 (0.40) | TLR4CYP4F2CYP4A11MAPTKMT2A | |
| SCHEMBL9757754 | 0.88 | MAPK1 (0.36) | TLR4ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL9758567 | 0.88 | CYP4F2 (0.44) | TLR4CYP4F2CYP4A11ALDH1A1LMNA | |
| SCHEMBL9757776 | 0.87 | TLR4 (0.32) | TLR4 | |
| SCHEMBL9758596 | 0.87 | CYP4F2 (0.47) | TLR4CYP4F2CYP4A11KMT2ANAAA | |
| SCHEMBL9758508 | 0.86 | CYP4F2 (0.39) | TLR4CYP4F2CYP4A11MAPTKMT2A | |
| SCHEMBL9757717 | 0.86 | TLR4 (0.32) | TLR4ALDH1A1 | |
| SCHEMBL9759035 | 0.85 | CYP4F2 (0.41) | CYP4F2CYP4A11MAPTKMT2ANAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4985583-A | Liquid Crystals | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1991-01-15 | — | — | US | disclosed |